Advertisement
ANI Pharma Guides FY23 Adj. EPS Below Estimates, But Revenues Above - Update
(RTTNews) - While reporting financial results for the fourth quarter on Thursday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) initiates adjusted earnings and net revenue guidance for the full-year 2023.
For fiscal 2023, the company now projects adjusted earnings in a range of $2.09 to $2.59 per share on net revenues between $360 million and $385 million, with purified cortrophin gel revenue at $80 million to $90 million.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.62 per share on revenues of $352.49 million for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use
Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.
RTTNews
|
Pred 372 dňami
ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution
ANI Pharmaceuticals, Inc. (ANIP) announced Monday that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Applications (ANDAs) for Methsuximide Capsules USP, 300 mg and Alendronate Sodium Oral Solution 70 mg (base)/75 mL.
RTTNews
|
Pred 743 dňami
ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets
ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets.
RTTNews
|
Pred 1070 dňami
Sensex, Nifty Marginally Lower In Early Trade; ITC Shares Down Over 3%
Indian shares were subdued on Wednesday amid delays in finalizing the India-U.S. trade agreement and investor anxiety around the ballooning U.S. debt levels.
RTTNews
|
Pred 2 minútami
Australian Market Trims Early Gains In Mid-market
The Australian stock market is trimming its early gains in mid-market moves on Wednesday, but extending the gains in the previous three sessions, with the benchmark S&P/ASX 200 staying just above 8,400 level, following the broadly positive cues from Wall Street overnight, with gains in energy and technology stocks and a mixed performance in mining and financial stocks.
RTTNews
|
Pred 56 minútami
Asian Markets Mixed Amid Cautious Trades
Asian stock markets are trading mixed on Wednesday, following the broadly positive cues from Wall Street overnight, as traders remain cautious amid the lack of concrete progress toward a broader trade agreement between the US and its trading partners, despite reaching temporary deals with some. The ongoing uncertainty surrounding the US-China trade relations continued to weigh on market sentiment.
RTTNews
|
Pred 1 h 8 min
Sensex, Nifty Seen Opening On Cautious Note
Indian shares may open on a flat note Wednesday as investors weigh global uncertainties and await cues from Nvidia's earnings results and the release of minutes from the Federal Reserve May meeting.
RTTNews
|
Pred 1 h 50 min
Rebound Predicted For Thai Stock Market
The Thai stock market on Tuesday snapped the two-day winning streak in which it had gained more than 5 points or 0.5 percent. The Stock Exchange of Thailand now rests just above the 1,160-point plateau, although it's likely to open to the upside on Wednesday.
RTTNews
|
Pred 2 h 22 min
